AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
AbbVie (ABBV) CEO Says He Will Not Retire Soon, Despite Rumors - Bloomberg
January 25, 2019 9:39 AM ESTAbbVie (NYSE: ABBV) CEO Says He Will Not Retire Soon, Despite Rumors - Bloomberg
AbbVie (ABBV) Misses Q4 EPS by 3c, Offers FY19 Guidance
January 25, 2019 7:43 AM ESTAbbVie (NYSE: ABBV) reported Q4 EPS of $1.90, $0.03 worse than the analyst estimate of $1.93. Revenue for the quarter came in at $8.31 billion versus the consensus estimate of $8.36 billion.
GUIDANCE:
AbbVie sees FY2019 EPS of $8.65-$8.75, versus the consensus of... More
